NZ195641A - 6-substituted-8-(pyrid-2-ylthiomethyl)ergolenes - Google Patents

6-substituted-8-(pyrid-2-ylthiomethyl)ergolenes

Info

Publication number
NZ195641A
NZ195641A NZ195641A NZ19564180A NZ195641A NZ 195641 A NZ195641 A NZ 195641A NZ 195641 A NZ195641 A NZ 195641A NZ 19564180 A NZ19564180 A NZ 19564180A NZ 195641 A NZ195641 A NZ 195641A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
iii
addition salt
acid addition
Prior art date
Application number
NZ195641A
Other languages
English (en)
Inventor
P Gull
G Bolliger
P Pfaeffli
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ195641A publication Critical patent/NZ195641A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ195641A 1979-11-27 1980-11-25 6-substituted-8-(pyrid-2-ylthiomethyl)ergolenes NZ195641A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1052679 1979-11-27

Publications (1)

Publication Number Publication Date
NZ195641A true NZ195641A (en) 1984-09-28

Family

ID=4364160

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ195641A NZ195641A (en) 1979-11-27 1980-11-25 6-substituted-8-(pyrid-2-ylthiomethyl)ergolenes

Country Status (16)

Country Link
JP (1) JPS5690087A (it)
AU (1) AU6468980A (it)
BE (1) BE886308A (it)
DE (1) DE3043210A1 (it)
DK (1) DK503580A (it)
ES (1) ES8202823A1 (it)
FI (1) FI803635A7 (it)
FR (1) FR2470131A1 (it)
GB (1) GB2065113A (it)
IL (1) IL61562A0 (it)
IT (1) IT8050243A0 (it)
NL (1) NL8006461A (it)
NZ (1) NZ195641A (it)
PT (1) PT72104B (it)
SE (1) SE8008234L (it)
ZA (1) ZA807420B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1200603B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutiche ad attivita dopaminergica

Also Published As

Publication number Publication date
JPS5690087A (en) 1981-07-21
DK503580A (da) 1981-05-28
FR2470131A1 (fr) 1981-05-29
SE8008234L (sv) 1981-05-28
FI803635L (fi) 1981-05-28
PT72104A (fr) 1980-12-01
DE3043210A1 (de) 1981-08-27
IT8050243A0 (it) 1980-11-25
NL8006461A (nl) 1981-07-01
ES497114A0 (es) 1982-02-16
BE886308A (fr) 1981-05-25
ZA807420B (en) 1982-07-28
GB2065113A (en) 1981-06-24
IL61562A0 (en) 1980-12-31
ES8202823A1 (es) 1982-02-16
FI803635A7 (fi) 1981-05-28
PT72104B (fr) 1982-01-28
AU6468980A (en) 1981-06-04

Similar Documents

Publication Publication Date Title
EP0304019A2 (en) Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid (syn isomer)
EP0000338A2 (en) Isoxazolo(5,4-c)pyridine derivatives, their preparation and pharmaceutical compositions containing them
DE3913245C2 (de) Chinoloncarbonsäure und deren Salze, Verfahren zu ihrer Herstellung sowie antibakterielle Mittel mit einem Gehalt derselben
EP1181294B1 (de) Neue derivate und analoga von galanthamin
TW202146402A (zh) 幷環化合物及其製備方法、藥物組合物和應用
CA2863772A1 (en) Process for preparing tiotropium bromide
AU2023203345A1 (en) Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound
US4180581A (en) N-9,10-dihydrolysergyl-m-aminobenzoic acid amide derivative
JPH06501031A (ja) ２，１４―ジ置換されたエルゴリン、その製造および医薬品中での使用
NZ195641A (en) 6-substituted-8-(pyrid-2-ylthiomethyl)ergolenes
EP0520435A2 (en) DC-89 derivatives
OA11952A (en) Polymorphs of crystalline (2-benzhydryl-1-azabicycloÄ2,2,2Üoct-3-yl)-5-isopropyl-2-methoxybenzyl)-ammoniumchloride as NK-1 receptor antagonists.
NO744175L (it)
CZ20011324A3 (cs) Způsob výroby derivátu beta-alaninu
US4235921A (en) Treating muscular spasms and convulsions with 3-azabicyclo[3.1.0]hexanes
US3428639A (en) Preparation of ergot alkaloids
US4235895A (en) Substituted 5H-dibenz[b,f]azepine
US3772299A (en) P'-alkoxy-ergotamines
US4607046A (en) 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate and pharmaceutical compositions
US4764517A (en) 8α-(N,N-diethylsulfamoylamino)-6-n-propyl ergoline useful as a prolactin secretion inhibitor, anti-parkinson, anti-depressant agent
EP0240986B1 (en) D-nor-7-ergoline derivatives, process for preparing them, pharmaceutical composition and use
KR20170143141A (ko) 바레니클린 유리염기의 결정질 다형체, 이의 제조방법 또는 용도
US3592816A (en) N-substituted piperazides of lysergic acid
EP1382608B1 (en) Sulfate of cephem compound
EP0026899A1 (de) Peptidergotalkaloide, Verfahren zu deren Herstellung, diese enthaltende pharmakologische Zusammensetzungen und ihre Anwendung bei der therapeutischen Behandlung